Literature DB >> 16806704

Selective migration and engraftment of bone marrow mesenchymal stem cells in rat lumbar dorsal root ganglia after sciatic nerve constriction.

María Florencia Coronel1, Patricia Leonor Musolino, Marcelo José Villar.   

Abstract

Bone marrow mesenchymal stem cells (MSCs) preferentially migrate to the injured hemisphere when administered intravenously to rats with traumatic or ischemic brain injuries. In this study, we have investigated the localization of MSCs injected into the lumbar-4 dorsal root ganglion (L4-DRG) of rats with a sciatic nerve single ligature nerve constriction (SLNC). MSCs were isolated by their adherence to plastic, cultured until confluence and labelled with Hoechst. Animals with a unilateral injection of MSCs were subjected to an ipsilateral, bilateral or contralateral SLNC. After 9 days, they were perfused and the lumbar DRGs were dissected out, cut in a cryostat and observed with a fluorescence microscope. Large numbers of Hoechst-positive cells were observed in the injected L4-DRG, distributed around primary afferent neurons, resembling the anatomical localization of glial cells. In animals with an ipsilateral SLNC, some cells were detected in the ipsilateral L3, L5 or L6-DRGs but not in the contralateral ganglia. In animals with a bilateral lesion, MSCs migrated to both the ipsilateral and contralateral DRGs whereas in animals with a contralateral ligature, MSCs migrated to the contralateral DRGs. These results suggest that MSCs preferentially engraft in DRGs hosting primary sensory neurons affected by a lesion of their peripheral branches. Further studies should be carried out in order to elucidate the molecular mechanisms involved in this migration and homing, in order to evaluate the possible use of MSCs as a new therapeutic strategy for the treatment of peripheral nerve neuropathies.

Entities:  

Mesh:

Year:  2006        PMID: 16806704     DOI: 10.1016/j.neulet.2006.06.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Ming Gu; Mineo Watanabe; Feng Wei; Ronald Dubner; George T-J Huang; Ke Ren
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

3.  Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Nicola Alessio; Giovanni Di Bernardo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Cell Mol Life Sci       Date:  2009-11-24       Impact factor: 9.261

4.  Targeted delivery of pharmacological agents into rat dorsal root ganglion.

Authors:  Livia Puljak; Sanja Lovric Kojundzic; Quinn H Hogan; Damir Sapunar
Journal:  J Neurosci Methods       Date:  2008-11-06       Impact factor: 2.390

5.  In vivo survival and differentiation of Friedreich ataxia iPSC-derived sensory neurons transplanted in the adult dorsal root ganglia.

Authors:  Serena Viventi; Stefano Frausin; Sara E Howden; Shiang Y Lim; Rocio K Finol-Urdaneta; Jeffrey R McArthur; Kwaku Dad Abu-Bonsrah; Wayne Ng; Jason Ivanusic; Lachlan Thompson; Mirella Dottori
Journal:  Stem Cells Transl Med       Date:  2021-03-18       Impact factor: 6.940

6.  Dorsal root ganglion - a potential new therapeutic target for neuropathic pain.

Authors:  Damir Sapunar; Sandra Kostic; Adriana Banozic; Livia Puljak
Journal:  J Pain Res       Date:  2012-02-16       Impact factor: 3.133

7.  Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.

Authors:  Yiling Si; Yali Zhao; Haojie Hao; Jiejie Liu; Yelei Guo; Yiming Mu; Jing Shen; Yu Cheng; Xiaobing Fu; Weidong Han
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

8.  Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.

Authors:  Hongwei Yu; Gregory Fischer; Allison D Ebert; Hsiang-En Wu; Xiaowen Bai; Quinn H Hogan
Journal:  Mol Pain       Date:  2015-02-12       Impact factor: 3.395

9.  Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects.

Authors:  Sabine Francois; Moubarak Mouiseddine; Bénédicte Allenet-Lepage; Jan Voswinkel; Luc Douay; Marc Benderitter; Alain Chapel
Journal:  Biomed Res Int       Date:  2013-11-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.